-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, LqqcUiV0VoohY6rNqK9y/MomzgeMBblmVUT1Q1vRnx5Jbnz/wPMoKXZY/COR6Qtp DIv21rAGtTRsvVLDdTyJzA== 0001179110-03-002843.txt : 20030702 0001179110-03-002843.hdr.sgml : 20030702 20030702124121 ACCESSION NUMBER: 0001179110-03-002843 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20030701 FILED AS OF DATE: 20030702 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BRUKER DALTONICS INC CENTRAL INDEX KEY: 0001109354 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 043110160 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 44 MANNING RD CITY: BILLERICA STATE: MA ZIP: 01821 MAIL ADDRESS: STREET 1: 44 MANNING RD CITY: BILLERICA STATE: MA ZIP: 01821 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LAUKIEN FRANK H CENTRAL INDEX KEY: 0001133649 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30833 FILM NUMBER: 03770618 BUSINESS ADDRESS: STREET 1: C/O BRUKER DALTONICS CITY: BILLERICA STATE: MA ZIP: 01821 MAIL ADDRESS: STREET 1: C/O BRUKER DALTONICS CITY: BILLERICA STATE: MA ZIP: 01821 4 1 edgar.xml FORM 4 -2003-07-01 X0101 4 2003-07-01 0 0001109354 BRUKER DALTONICS INC BRKR 0001133649 LAUKIEN FRANK H 1 1 1 0 CEO, President Common Stock 2003-07-01 4 A 0 4704818 0 A 13004022 D Common Stock 2003-07-01 4 A 0 184297 0 A 985094 I By former spouse. Filer retained voting rights. Stock Option (right to buy) 2.79 2003-07-01 4 A 0 31500 2.79 A 2003-04-28 2010-04-28 Common Stock 31500 31500 D Stock Option (right to buy) 3.33 2003-07-01 4 A 0 6300 3.33 A 2003-05-07 2012-05-07 Common Stock 6300 6300 D Stock Option (right to buy) 3.59 2003-07-01 4 A 0 6300 3.59 A 2004-05-07 2013-05-07 Common Stock 6300 6300 D Acquired in exchange for 7,467,965 shares of Bruker AXS Inc. in connection with the merger of Bruker AXS Inc. into Bruker Daltonics Inc., now known as Bruker BioSciences Corporation (the "Merger"). On the effective date of the Merger, the closing price of Bruker Daltonics Inc.'s common stock was $5.50 per share, and the closing price of Bruker AXS Inc's stock was $3.38 per share. Acquired in exchange for 292,535 shares of Bruker AXS Inc. in connection with the Merger. On the effective date of the Merger, the closing price of Bruker Daltonics Inc.'s common stock was $5.50 per share, and the closing price of Bruker AXS Inc's stock was $3.38 per share. In connection with the Merger, filer's option to receive 50,000 shares of Bruker AXS Inc. common stock was converted into an option to purchase 31,500 shares of Bruker BioSciences Corporation's common stock at $2.79 per share. In connection with the Merger, filer's option to receive 10,000 shares of Bruker AXS Inc. common stock was converted into an option to purchase 6,300 shares of Bruker BioSciences Corporation's common stock at $3.33 per share. In connection with the Merger, filer's option to receive 10,000 shares of Bruker AXS Inc. common stock was converted into an option to purchase 6,300 shares of Bruker BioSciences Corporation's common stock at $3.58 per share. Frank H. Laukien 2003-07-01 -----END PRIVACY-ENHANCED MESSAGE-----